Skip to main content
Register
Medicine Matters Oncology
SEARCH
Menu 1 2 3 4

ESMO Virtual Congress 2020

BREAST CANCER


Access all our news articles and expert interviews on the most practice-influencing breast cancer data from the congress.


Expert video interviews

IMpassion130 and IMpassion131 trials of atezolizumab in TNBC: The difference a taxane makes?

monarchE and PALLAS trials: A tale of two CDK4/6 inhibitors

ASCENT trial: Positive results for sacituzumab govitecan in metastatic TNBC

OS results from SOLAR-1 trial of alpelisib

IMpassion031 study supports neoadjuvant atezolizumab in early TNBC

PALLAS trial: Adjuvant palbociclib strikes out in early-stage breast cancer

Latest research news

06-10-2020 | ESMO 2020 | Conference coverage | News

pCR predicts 5-year survival for early-stage, HR-positive, HER2-positive breast cancer

02-10-2020 | ESMO 2020 | Conference coverage | News

PALLAS: No reduction in relapse risk with adjuvant palbociclib in early breast cancer

28-09-2020 | ESMO 2020 | Conference coverage | News

Neoadjuvant atezolizumab–chemotherapy improves TNBC pathologic response

24-09-2020 | ESMO 2020 | Conference coverage | News

FLIPPER: Postmenopausal breast cancer patients benefit from first-line palbociclib–fulvestrant

23-09-2020 | ESMO 2020 | Conference coverage | News

Sacituzumab govitecan boosts pretreated metastatic TNBC outcomes

23-09-2020 | ESMO 2020 | Conference coverage | News

IMpassion131 rules out atezolizumab–paclitaxel duo in metastatic TNBC

22-09-2020 | ESMO 2020 | Conference coverage | News

monarchE: Adjuvant abemaciclib reduces relapse risk in high-risk early breast cancer

20-09-2020 | ESMO 2020 | Conference coverage | News

IMpassion130: ‘Clinically meaningful’ OS boost with atezolizumab in PD-L1-positive advanced TNBC


Medicine Matters conference coverage is brought to you in partnership with medwireNews



Image Credits